Swiss National Bank - MYOVANT SCIENCES LTD ownership

MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 31 filers reported holding MYOVANT SCIENCES LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of MYOVANT SCIENCES LTD
ValueSharesWeighting
Q4 2022$2,809,232
+53.8%
104,200
+2.5%
0.00%
+100.0%
Q3 2022$1,827,000
+47.6%
101,700
+2.1%
0.00%0.0%
Q2 2022$1,238,000
+5.4%
99,600
+12.9%
0.00%0.0%
Q1 2022$1,175,000
-6.7%
88,200
+9.0%
0.00%0.0%
Q4 2021$1,260,000
-30.6%
80,9000.0%0.00%0.0%
Q3 2021$1,815,000
-0.5%
80,900
+1.0%
0.00%0.0%
Q2 2021$1,824,000
+7.0%
80,100
-3.3%
0.00%0.0%
Q1 2021$1,704,000
-24.3%
82,800
+1.6%
0.00%
-50.0%
Q4 2020$2,251,000
+96.6%
81,5000.0%0.00%
+100.0%
Q3 2020$1,145,000
-30.8%
81,500
+1.6%
0.00%0.0%
Q2 2020$1,654,000
+180.3%
80,200
+2.6%
0.00%0.0%
Q1 2020$590,000
-50.7%
78,200
+1.4%
0.00%0.0%
Q4 2019$1,197,000
+215.0%
77,100
+5.6%
0.00%
Q3 2019$380,000
-42.5%
73,0000.0%0.00%
-100.0%
Q2 2019$661,000
-11.3%
73,000
+134.0%
0.00%0.0%
Q1 2019$745,000
+50.2%
31,200
+3.3%
0.00%0.0%
Q4 2018$496,000
-34.0%
30,200
+6.7%
0.00%0.0%
Q3 2018$751,000
+16.1%
28,3000.0%0.00%0.0%
Q2 2018$647,000
+7.5%
28,3000.0%0.00%0.0%
Q1 2018$602,000
+89.9%
28,300
+12.7%
0.00%
Q4 2017$317,000
-18.3%
25,1000.0%0.00%
Q3 2017$388,000
+32.0%
25,1000.0%0.00%
Q2 2017$294,00025,1000.00%
Other shareholders
MYOVANT SCIENCES LTD shareholders Q4 2018
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 65,000$808,0001.13%
Bellevue Group AG 5,919,639$73,581,0001.04%
Rhenman & Partners Asset Management AB 310,000$3,853,0000.44%
Hennion & Walsh Asset Management, Inc. 279,335$3,472,0000.22%
TORRAY INVESTMENT PARTNERS LLC 81,621$1,015,0000.19%
PLATINUM INVESTMENT MANAGEMENT LTD 302,120$3,755,0000.14%
Virtus ETF Advisers LLC 22,356$278,0000.10%
Tarbox Family Office, Inc. 27,500$342,0000.08%
BOURGEON CAPITAL MANAGEMENT LLC 15,200$189,0000.05%
JANUS HENDERSON GROUP PLC 5,449,107$67,735,0000.05%
View complete list of MYOVANT SCIENCES LTD shareholders